Furthermore, of 24 retinoblastoma tumors in which RB1 bi-allelic inactivating mutations were identified, the second allele was mutated by LOH in 58% of tumors with nonsense substitution and in 75% of tumors with methylation of the promoter. The gene discussed is RB1; the disease is retinoblastoma.